1008517-68-7 Usage
Chemical Structure
Consists of a benzene ring with a hydroxyl group (-OH) and a chloroethyl group (-CH2CH2Cl) attached to it.
Application
Pharmaceutical Synthesis: Used in the synthesis of pharmaceuticals.
Industrial Production: Employed in the production of various industrial products.
Organic Compound Manufacturing: Serves as a building block in the manufacturing of other organic compounds.
Versatility
The presence of the chloroethyl group makes it valuable as a starting material for the preparation of a wide range of organic compounds.
Importance in Organic Synthesis
Acts as a versatile and important chemical in the field of organic synthesis.
Enables the creation of diverse organic compounds due to its structural properties.
Usage
Commonly utilized in pharmaceutical, industrial, and organic synthesis applications.
Key Functional Groups
Benzene Ring
Hydroxyl Group (-OH)
Chloroethyl Group (-CH2CH2Cl)
Check Digit Verification of cas no
The CAS Registry Mumber 1008517-68-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,8,5,1 and 7 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1008517-68:
(9*1)+(8*0)+(7*0)+(6*8)+(5*5)+(4*1)+(3*7)+(2*6)+(1*8)=127
127 % 10 = 7
So 1008517-68-7 is a valid CAS Registry Number.
1008517-68-7Relevant articles and documents
NEW PYRIDONE DERIVATIVES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS
-
Page/Page column 77-78, (2008/06/13)
The present invention relates to compounds of general formula (I) wherein the groups and radicals B, k, L, U,V, W, X, Y, Z, R1, R2, have the meanings given in claim 1. Moreover the invention relates to pharmaceutical compositions containing at least one compound according to the invention. By virtue of their MCH- receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.
3,6-DISUBSTITUTED AZABICYCLO HEXANE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
-
Page 63, (2008/06/13)
This invention generally relates to derivatives of 3,6 disubstituted azabicyclo hexanes.The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors.The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.